高效镇痛药——盐酸二氢埃托啡片

来源 :中国药理学与毒理学杂志 | 被引量 : 0次 | 上传用户:pansheng5
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
盐酸二氢埃托啡片是我国创新研制成功并经中华人民共和国卫生部批准的第一个高效镇痛药。它是当今国内外止痛作用最强,用量最小的药物。舌下含化微克级的剂量即可解除晚期癌症疼痛(包括使用哌替啶或吗啡止痛无效者)以及创伤、手术后等的剧痛。十年来,经数十万人次的临床应用表明:该药起效快,效果好,使用方便。至今未见身体依赖性。为此,曾获国家科技进步奖二等奖和首届个国医药科技成果展优秀奖。现经中华人民 Dihydroetorphine hydrochloride tablets are the first highly effective analgesics successfully developed in China and approved by the Ministry of Health of People’s Republic of China. It is the strongest analgesic effect at home and abroad, the smallest amount of drugs. Sublingual microglial doses to relieve advanced cancer pain (including the use of pethidine or morphine pain relief ineffective) and trauma, surgery and other pain. Decades, clinical application of hundreds of thousands of people show that: the drug rapid onset, the effect is good, easy to use. So far no physical dependence. To this end, won the second prize of national science and technology progress award and the first national medicine science and technology exhibition excellence award. Now the Chinese people
其他文献
作者观察了7例Cushing病患者和6例正常人血N-POMC和皮质醇对静脉注射CRH或CRH加纳络酮的反应。Cushing病患者对CRH的反应与正常人相似;而在加用大剂量纳络酮之后,却没有如正常人一样出现进一步增高反应。纳络酮在正常人可能通过阻断类阿片肽对内源性CRH的抑制作用而使反应进一步升高,在Cushing病患者可能存在着更强的CRH抑制因素,因而加用纳络酮不起作用。